Literature DB >> 27378612

Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Georg Fuernau1,2,3, Karl Fengler4, Steffen Desch5,6, Ingo Eitel5,6, Franz-Josef Neumann7, Hans-Georg Olbrich8, Antoinette de Waha9, Suzanne de Waha5,6, Gert Richardt10, Marcus Hennersdorf11, Klaus Empen12, Rainer Hambrecht13, Christian Jung14, Michael Böhm15, Janine Pöss5,6, Ruth H Strasser16, Steffen Schneider17, Taoufik Ouarrak17, Gerhard Schuler4, Karl Werdan18, Uwe Zeymer17, Holger Thiele5,6.   

Abstract

BACKGROUND: In myocardial infarction without cardiogenic shock (CS), the affected coronary vessel has significant influence on the final infarct size and patient prognosis. CS data on this relation are scarce. The objective of this study was to determine the prognostic relevance of the culprit lesion location in patients with CS complicating acute myocardial infarction.
METHODS: In the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial patients with CS were randomized to therapy with intraaortic balloon pump or control. Additional CS patients not eligible for the randomized trial were included in a registry. We compared the location of the culprit lesions in these patients with regard to the affected coronary vessel [left main (LM), left anterior descending (LAD), left circumflex (LCX) and right coronary artery (RCA)] and location within the vessel (proximal, mid or distal) regarding short- and long-term outcome.
RESULTS: Of 758 patients, the majority had the culprit lesion in the LAD (44 %) compared to RCA (27 %), LCX (19 %) or LM (10 %). Proximal lesions were more frequent than mid or distal culprit lesions (60 vs. 27 vs. 13 %, p < 0.001). No differences were observed for mortality with respect to either culprit vessel (log-rank p value = 0.54). In contrast, a higher mortality was observed for patients with distal culprit lesions after 1 year (log-rank p value = 0.04). This difference persisted after multivariable adjustment (hazard ratio for distal lesions 1.40; 95 % confidential interval 1.03-1.90; p = 0.03).
CONCLUSION: For patients with CS complicating myocardial infarction, the culprit vessel seems to be unrelated with mortality whereas distal culprit lesions may have a worse outcome.

Entities:  

Keywords:  Cardiogenic shock; Culprit lesion; Infarct-related artery; Mortality; Myocardial infarction

Mesh:

Year:  2016        PMID: 27378612     DOI: 10.1007/s00392-016-1017-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  39 in total

1.  Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.

Authors:  Enno Boudriot; Holger Thiele; Thomas Walther; Christoph Liebetrau; Peter Boeckstegers; Tilmann Pohl; Bruno Reichart; Harald Mudra; Florian Beier; Brigitte Gansera; Franz-Josef Neumann; Michael Gick; Thomas Zietak; Steffen Desch; Gerhard Schuler; Friedrich-Wilhelm Mohr
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

2.  Prediction of clinical outcomes in patients with unprotected left main trifurcation lesions treated by drug-eluting stents: importance of 2-stent technique and SYNTAX score.

Authors:  Shao-Liang Chen; Fey Ye; Jun-Jie Zhang; Zuo-Ying Hu; Nai-Liang Tian; Jun-Xia Zhang; Tak W Kwan
Journal:  J Interv Cardiol       Date:  2010-07-19       Impact factor: 2.279

3.  Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre.

Authors:  Ulrike M Müller; Ingo Eitel; Kristina Eckrich; Sandra Erbs; Axel Linke; Sven Möbius-Winkler; Meinhard Mende; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-10-24       Impact factor: 5.460

4.  Cardiogenic shock: to pump or not to pump?

Authors:  Holger Thiele; Gerhard Schuler
Journal:  Eur Heart J       Date:  2009-01-30       Impact factor: 29.983

5.  Stents versus coronary-artery bypass grafting for left main coronary artery disease.

Authors:  Ki Bae Seung; Duk-Woo Park; Young-Hak Kim; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Sung-Cheol Yun; Hyeon-Cheol Gwon; Myung-Ho Jeong; Yangsoo Jang; Hyo-Soo Kim; Pum Joon Kim; In-Whan Seong; Hun Sik Park; Taehoon Ahn; In-Ho Chae; Seung-Jea Tahk; Wook-Sung Chung; Seung-Jung Park
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

6.  Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Authors:  Holger Thiele; Gerhard Schuler; Franz-Josef Neumann; Jörg Hausleiter; Hans-Georg Olbrich; Bettina Schwarz; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Suzanne de Waha; Ingo Eitel; Rainer Hambrecht; Michael Böhm; Volkhard Kurowski; Bernward Lauer; Hans-Heinrich Minden; Hans-Reiner Figulla; Rüdiger C Braun-Dullaeus; Ruth H Strasser; Kristin Rochor; Sebastian K G Maier; Helge Möllmann; Steffen Schneider; Henning Ebelt; Karl Werdan; Uwe Zeymer
Journal:  Am Heart J       Date:  2012-06       Impact factor: 4.749

7.  Location of coronary culprit lesions at autopsy in 41 nondiabetic patients with acute myocardial infarction.

Authors:  Jeffrey B Geske; William D Edwards; Ryan J MacDonald; David R Holmes
Journal:  Am J Forensic Med Pathol       Date:  2010-09       Impact factor: 0.921

8.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

9.  Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.

Authors:  Juhana Karha; Sabina A Murphy; Ajay J Kirtane; James A de Lemos; Julian M Aroesty; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

10.  Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Karl Fengler; Georg Fuernau; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Janine Poess; Ruth Strasser; Steffen Schneider; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2014-10-07       Impact factor: 5.460

View more
  8 in total

1.  Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.

Authors:  Jasper Boeddinghaus; Tobias Reichlin; Thomas Nestelberger; Raphael Twerenbold; Yvette Meili; Karin Wildi; Petra Hillinger; Maria Rubini Giménez; Janosch Cupa; Lukas Schumacher; Marie Schubera; Patrick Badertscher; Sydney Corbière; Karin Grimm; Christian Puelacher; Zaid Sabti; Dayana Flores Widmer; Nicolas Schaerli; Nikola Kozhuharov; Samyut Shrestha; Tobias Bürge; Patrick Mächler; Michael Büchi; Katharina Rentsch; Òscar Miró; Beatriz López; F Javier Martin-Sanchez; Esther Rodriguez-Adrada; Beata Morawiec; Damian Kawecki; Eva Ganovská; Jiri Parenica; Jens Lohrmann; Andreas Buser; Dagmar I Keller; Stefan Osswald; Christian Mueller
Journal:  Clin Res Cardiol       Date:  2017-02-01       Impact factor: 5.460

2.  Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock.

Authors:  Christian Jung; Georg Fuernau; Ingo Eitel; Steffen Desch; Gerhard Schuler; Malte Kelm; Volker Adams; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-12-08       Impact factor: 5.460

3.  Bioresorbable vascular scaffold implantation to bail out nail gun injury in ST-segment myocardial infarction.

Authors:  Torsten Schütz; Friedrich P Krönig; Christoph Karmeinsky; Oliver Weingärtner
Journal:  Clin Res Cardiol       Date:  2017-09-13       Impact factor: 5.460

4.  Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.

Authors:  Tina Backhaus; Andreas Fach; Johannes Schmucker; Eduard Fiehn; Daniela Garstka; Janina Stehmeier; Rainer Hambrecht; Harm Wienbergen
Journal:  Clin Res Cardiol       Date:  2017-12-11       Impact factor: 5.460

5.  Culprit vessel-related myocardial mechanics and prognostic implications following acute myocardial infarction.

Authors:  Sören J Backhaus; Johannes T Kowallick; Thomas Stiermaier; Torben Lange; Alexander Koschalka; Jenny-Lou Navarra; Joachim Lotz; Shelby Kutty; Boris Bigalke; Matthias Gutberlet; Hans-Josef Feistritzer; Gerd Hasenfuß; Holger Thiele; Andreas Schuster; Ingo Eitel
Journal:  Clin Res Cardiol       Date:  2019-07-05       Impact factor: 5.460

6.  Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock.

Authors:  Tuija Sabell; Marek Banaszewski; Johan Lassus; Markku S Nieminen; Heli Tolppanen; Toni Jäntti; Anu Kataja; Mari Hongisto; Lars Køber; Alessandro Sionis; John Parissis; Tuukka Tarvasmäki; Veli-Pekka Harjola; Raija Jurkko
Journal:  ESC Heart Fail       Date:  2020-03-12

7.  Cardiogenic shock due to left main related myocardial infarction: is revascularization enough?

Authors:  Francisco Galván-Román; Elena Puerto; Roberto Martín-Asenjo; Albert Ariza-Solé
Journal:  J Geriatr Cardiol       Date:  2022-02-28       Impact factor: 3.327

8.  Association between baseline smoking status and clinical outcomes following myocardial infarction.

Authors:  Seok Oh; Ju Han Kim; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Youngkeun Ahn; Myung Ho Jeong
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.